NO995681L - Fremgangsmåte for å fremstille fluorbiprofen-tabletter - Google Patents
Fremgangsmåte for å fremstille fluorbiprofen-tabletterInfo
- Publication number
- NO995681L NO995681L NO995681A NO995681A NO995681L NO 995681 L NO995681 L NO 995681L NO 995681 A NO995681 A NO 995681A NO 995681 A NO995681 A NO 995681A NO 995681 L NO995681 L NO 995681L
- Authority
- NO
- Norway
- Prior art keywords
- tablets
- mixture
- fluorobiprofen
- preparing
- forming
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 abstract 2
- 229960002390 flurbiprofen Drugs 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 2
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002798 polar solvent Substances 0.000 abstract 1
- 239000007916 tablet composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9710521.7A GB9710521D0 (en) | 1997-05-22 | 1997-05-22 | Process |
| PCT/EP1998/003167 WO1998052539A1 (en) | 1997-05-22 | 1998-05-20 | Process for making flurbiprofen lozenges |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995681D0 NO995681D0 (no) | 1999-11-19 |
| NO995681L true NO995681L (no) | 1999-11-19 |
Family
ID=10812840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995681A NO995681L (no) | 1997-05-22 | 1999-11-19 | Fremgangsmåte for å fremstille fluorbiprofen-tabletter |
Country Status (31)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4040878B2 (ja) | 1999-12-09 | 2008-01-30 | レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド | 治療薬 |
| EP1284729A4 (en) * | 2000-04-13 | 2007-12-19 | Mayo Foundation | REDUCTION AGENTS OF A (BETA) 42 |
| JP4886107B2 (ja) * | 2000-10-13 | 2012-02-29 | サンスター株式会社 | 歯周病予防用口腔内溶解錠 |
| EP1603548A4 (en) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
| CA2532207A1 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| FR2865648B1 (fr) | 2004-02-03 | 2006-06-30 | Philippe Perovitch | Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede |
| US20070293538A1 (en) * | 2004-04-13 | 2007-12-20 | Myriad Genetics, Incorporated | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders |
| WO2005108683A1 (en) * | 2004-04-29 | 2005-11-17 | Keystone Retaining Wall Systems, Inc. | Veneers for walls, retaining walls and the like |
| WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006020853A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006082501A2 (en) | 2005-02-03 | 2006-08-10 | Nycomed Pharma As | Fast wet-massing method for the preparation of calcium-containing compositions |
| GB2423710A (en) | 2005-03-01 | 2006-09-06 | Boots Healthcare Int Ltd | Lozenge production process |
| WO2007014124A2 (en) * | 2005-07-22 | 2007-02-01 | Myriad Genetics, Inc. | High drug load formulations and dosage forms |
| RU2008116871A (ru) * | 2005-11-02 | 2009-12-10 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US) | Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения |
| EP2046119A2 (en) * | 2006-07-07 | 2009-04-15 | Myriad Genetics, Inc. | Treatment of psychiatric disorders |
| CA2680238A1 (en) * | 2007-07-23 | 2009-01-29 | Teikoku Pharma Usa, Inc. | Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same |
| WO2010020772A2 (en) * | 2008-08-22 | 2010-02-25 | Reckitt Benckiser Healthcare (Uk) Limited | Improvements in or relating to compositions |
| IT1397132B1 (it) | 2009-12-01 | 2013-01-04 | Alfa Wassermann Spa | Composizioni comprendenti antiinfiammatori non steroidei. |
| IT1406107B1 (it) * | 2010-12-13 | 2014-02-14 | Alfa Wassermann Spa | Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso. |
| CA2860373C (en) | 2011-04-29 | 2017-08-15 | Moberg Pharma Ab | Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat |
| EP2609911A1 (en) * | 2011-12-29 | 2013-07-03 | Sanovel Ilac Sanayi ve Ticaret A.S. | A novel process for preparing orally disintegrating flurbiprofen formulations |
| FR2997856B1 (fr) * | 2012-11-14 | 2015-04-24 | Pf Medicament | Pastille medicamenteuse a base d'ibuprofene sodique dihydrate |
| US20180228832A1 (en) * | 2015-08-18 | 2018-08-16 | Pharma Seeds Create, Llc | Stomatological composition containing nsaid or heparin compound |
| WO2020013781A2 (en) * | 2018-03-27 | 2020-01-16 | Pisak Mehmet Nevzat | Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4389393A (en) | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4666716A (en) * | 1984-09-04 | 1987-05-19 | Richardson-Vicks Inc. | Antidiarrheal compositions and use thereof |
| RU2026670C1 (ru) * | 1988-10-05 | 1995-01-20 | Дзе Апджон Компани | Способ получения тонкодисперсного твердого фармацевтического вещества |
| IT1243342B (it) | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
| IT1244698B (it) * | 1991-02-01 | 1994-08-08 | Gentili Ist Spa | Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale |
| US5302394A (en) * | 1992-07-14 | 1994-04-12 | Mcneil-Ppc, Inc. | Dextromethorphan continuous lozenge manufacturing process |
| US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
| TW442287B (en) | 1995-06-13 | 2001-06-23 | American Home Produits Corp | Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac) |
| US5614207A (en) * | 1995-06-30 | 1997-03-25 | Mcneil-Ppc, Inc. | Dry mouth lozenge |
| GB9523833D0 (en) * | 1995-11-22 | 1996-01-24 | Boots Co Plc | Medical treatment |
-
1997
- 1997-05-22 GB GBGB9710521.7A patent/GB9710521D0/en active Pending
-
1998
- 1998-05-20 RU RU99126868/14A patent/RU2203046C2/ru not_active IP Right Cessation
- 1998-05-20 EP EP98929394A patent/EP0983059B1/en not_active Expired - Lifetime
- 1998-05-20 AT AT98929394T patent/ATE245021T1/de not_active IP Right Cessation
- 1998-05-20 IL IL13299998A patent/IL132999A0/xx not_active IP Right Cessation
- 1998-05-20 DE DE69816440T patent/DE69816440T2/de not_active Expired - Lifetime
- 1998-05-20 PT PT98929394T patent/PT983059E/pt unknown
- 1998-05-20 ES ES98929394T patent/ES2202871T3/es not_active Expired - Lifetime
- 1998-05-20 HU HU0002121A patent/HU224954B1/hu not_active IP Right Cessation
- 1998-05-20 CN CNB988051230A patent/CN1154480C/zh not_active Expired - Fee Related
- 1998-05-20 WO PCT/EP1998/003167 patent/WO1998052539A1/en not_active Application Discontinuation
- 1998-05-20 DK DK98929394T patent/DK0983059T3/da active
- 1998-05-20 KR KR1019997010700A patent/KR20010012739A/ko not_active Ceased
- 1998-05-20 PL PL336624A patent/PL190947B1/pl unknown
- 1998-05-20 TR TR1999/02725T patent/TR199902725T2/xx unknown
- 1998-05-20 ZA ZA984260A patent/ZA984260B/xx unknown
- 1998-05-20 CA CA002290830A patent/CA2290830C/en not_active Expired - Fee Related
- 1998-05-20 US US09/403,771 patent/US6194003B1/en not_active Expired - Lifetime
- 1998-05-20 AU AU79165/98A patent/AU725760B2/en not_active Ceased
- 1998-05-20 NZ NZ500664A patent/NZ500664A/xx not_active IP Right Cessation
- 1998-05-20 SK SK1588-99A patent/SK283701B6/sk not_active IP Right Cessation
- 1998-05-20 JP JP54999298A patent/JP2001527567A/ja not_active Ceased
- 1998-05-20 CZ CZ19994120A patent/CZ290816B6/cs not_active IP Right Cessation
- 1998-05-20 BR BR9809651-6A patent/BR9809651A/pt not_active IP Right Cessation
- 1998-05-20 UA UA99127003A patent/UA53714C2/uk unknown
- 1998-05-20 ID IDW991324A patent/ID22949A/id unknown
- 1998-05-21 AR ARP980102364A patent/AR015812A1/es not_active Application Discontinuation
- 1998-05-21 IN IN1090MA1998 patent/IN187837B/en unknown
- 1998-05-22 MY MYPI98002295A patent/MY118410A/en unknown
-
1999
- 1999-11-15 BG BG103881A patent/BG103881A/xx unknown
- 1999-11-19 NO NO995681A patent/NO995681L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO995681L (no) | Fremgangsmåte for å fremstille fluorbiprofen-tabletter | |
| CA2225286A1 (en) | A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof | |
| RU98123589A (ru) | Композиция для орального введения, способ снижения обжигающего послевкусия композиций пропионовой кислоты | |
| DE2966767D1 (en) | Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them | |
| AU7061587A (en) | Controlled-release pharmaceutical composition for periodontal diseases | |
| ES8602599A1 (es) | Un procedimiento de preparar un derivado de trans-1,2-diaminoxiclohexil-amida. | |
| IE821861L (en) | Pharmaceutical compositions | |
| EP0003199A3 (en) | Tetrahydropyridinyl indole derivatives and their salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them | |
| IL112957A0 (en) | Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them | |
| GEP20033062B (en) | Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative | |
| DK136487D0 (da) | Farmaceutisk praeparat indeholdende ibuprofen og fremgangsmaade til fremstilling deraf | |
| EP0295212A3 (en) | Process for preparing a pharmaceutical composition | |
| HUT48232A (en) | Process for producing new biphenyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| DE2966706D1 (en) | Substituted anthranilic acid amides, process for their preparation, pharmaceutical compositions containing them and their preparation | |
| AU7292794A (en) | A method of manufacturing a laxative composition dosage unit and dosage units obtained thereby | |
| DE3265210D1 (en) | Novel compounds with antiinflammatory and analgesic activity, process for the preparation thereof and pharmaceutical compositions therefrom | |
| ES8604731A1 (es) | Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina | |
| KR890007745A (ko) | 약학조성물 및 그의 제조방법 | |
| ES8601687A1 (es) | Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph | |
| ES8506717A1 (es) | Procedimiento de preparacion de nuevos derivados de 1, 3-dihidro-6-metil-7-hidroxi-furo-(3, 4-c)-piridina | |
| FR2769839B1 (fr) | Composition anhydre a base de lactulose | |
| HUT34489A (en) | Process for preparing 7-oxo-4-thia-1-aza-bicyclo/3,2,0/hept-2-ene derivatives and pharmaceutical compositions containing thereof as active substances | |
| KR890001559A (ko) | 트라피딜을 함유하는 제약 조성물, 그의 제조방법 및 관련된 치료 용도 | |
| DE69102143D1 (de) | Spiramycin enthaltende arzneimittel und verfahren zu deren herstellung. | |
| DE3162851D1 (en) | Tetrahydrothiopyrano(3,2-b)indole derivatives, process for their preparation and pharmaceutical composition containing these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |